Innovative Medical Management Co.,Ltd. (SHE:002173)
China flag China · Delayed Price · Currency is CNY
17.22
+0.58 (3.49%)
Oct 30, 2026, 3:04 PM CST

SHE:002173 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash & Equivalents
307.41327.58137.98563.08658.48225.71
Trading Asset Securities
108.8584.01287.820.08-574.04
Cash & Short-Term Investments
416.26411.59425.78583.16658.48799.75
Cash Growth
-4.84%-3.33%-26.99%-11.44%-17.66%-14.90%
Accounts Receivable
72.7489.7124.18102.8451.5683.36
Other Receivables
1.584.292.232.655.727.15
Receivables
74.3293.99126.41105.4957.2890.51
Inventory
33.7336.3142.0141.8149.2543.04
Other Current Assets
6.362.434.652.66.636.72
Total Current Assets
530.68544.32598.85733.06771.65940.02
Property, Plant & Equipment
1,1991,2551,2731,3501,3761,385
Long-Term Investments
40.79147.11143.5815.2217.8619.76
Goodwill
36.8836.880.990.990.990.99
Other Intangible Assets
141.52148.27127.41129.56121.78125.16
Long-Term Deferred Tax Assets
17.2417.424.7917.0114.3813.8
Long-Term Deferred Charges
26.130.1331.8434.0535.7852.56
Other Long-Term Assets
2.50.493.081.781.647.15
Total Assets
1,9942,1792,2042,2812,3402,544

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Accounts Payable
150.93166.64195.24157.66150.25183.37
Accrued Expenses
39.1452.755451.6750.9658.98
Short-Term Debt
53.0343.2541.0630.1723.113
Current Portion of Long-Term Debt
20.91----9.02
Current Portion of Leases
-1411.9818.0513.7517.86
Current Income Taxes Payable
5.60.40.870.10.881.76
Current Unearned Revenue
2.83.433.743.575.3651.99
Other Current Liabilities
11.3715.7514.3164.2178.0519.98
Total Current Liabilities
283.77296.22321.21325.43322.36345.97
Long-Term Debt
-88---
Long-Term Leases
11.6517.0415.1420.3323.2938.12
Long-Term Unearned Revenue
4.613.853.554.174.795.2
Long-Term Deferred Tax Liabilities
46.147.3244.0244.4945.0145.57
Other Long-Term Liabilities
18.7342.2734.9315.9839.17130.42
Total Liabilities
364.87414.7426.85410.39434.63565.27

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Common Stock
441.28441.28441.28449.04453.08453.61
Additional Paid-In Capital
2,7172,7172,7082,7492,7442,744
Retained Earnings
-1,489-1,408-1,373-1,279-1,245-1,171
Treasury Stock
-50.01---48.4-48.4-48.4
Total Common Equity
1,6191,7501,7761,8701,9041,978
Minority Interest
10.7914.530.90.930.941.11
Shareholders' Equity
1,6291,7641,7771,8711,9051,979
Total Liabilities & Equity
1,9942,1792,2042,2812,3402,544

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Total Debt
85.5982.2976.1868.5460.1568
Net Cash (Debt)
330.67329.3349.6514.62598.33731.75
Net Cash Growth
-9.67%-5.81%-32.06%-13.99%-18.23%-21.38%
Net Cash Per Share
0.790.760.781.201.341.63
Filing Date Shares Outstanding
438.37441.28441.28441.28445.32445.85
Total Common Shares Outstanding
438.37441.28441.28441.28445.32445.85
Working Capital
246.9248.1277.64407.63449.28594.05
Book Value Per Share
3.693.974.034.244.284.44
Tangible Book Value
1,4401,5651,6481,7401,7811,852
Tangible Book Value Per Share
3.293.553.733.944.004.15
Buildings
---1,2571,1121,109
Machinery
-678.33688.35749.16795.26828.42
Construction In Progress
-22.889.455.95112.5647.31